• 1. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 2. Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
  Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227
• 3. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 4. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 5. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143

Introduction to 6-Cyanoimidazo[1,2-a]pyridine-2-carboxylic acid (CAS No. 1020035-67-9)

6-Cyanoimidazo[1,2-a]pyridine-2-carboxylic acid, identified by the Chemical Abstracts Service number 1020035-67-9, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the imidazopyridine class, a scaffold that has been extensively explored for its potential biological activities. The structural features of 6-Cyanoimidazo[1,2-a]pyridine-2-carboxylic acid, particularly the presence of a cyano group and a carboxylic acid moiety, contribute to its unique chemical properties and reactivity, making it a valuable building block in the synthesis of more complex molecules.

The imidazopyridine core is a privileged structure in drug discovery, owing to its ability to interact with various biological targets. 6-Cyanoimidazo[1,2-a]pyridine-2-carboxylic acid has been studied for its potential applications in the development of small-molecule inhibitors and probes. Recent research has highlighted its role in modulating enzyme activity and receptor binding, which are critical for therapeutic intervention. The cyano group at the 6-position enhances the electrophilicity of the molecule, facilitating further functionalization and derivatization, while the carboxylic acid at the 2-position provides a site for conjugation with other pharmacophores.

In the context of modern drug design, 6-Cyanoimidazo[1,2-a]pyridine-2-carboxylic acid has been incorporated into various lead compounds targeting diseases such as cancer, inflammation, and neurodegeneration. Its structural motif is particularly relevant in the development of kinase inhibitors, where imidazopyridines have shown promise due to their ability to mimic natural substrates and disrupt aberrant signaling pathways. For instance, studies have demonstrated that derivatives of this compound can inhibit tyrosine kinases involved in tumor growth and progression.

One of the most compelling aspects of 6-Cyanoimidazo[1,2-a]pyridine-2-carboxylic acid is its synthetic versatility. The presence of both a cyano group and a carboxylic acid allows for multiple reaction pathways, including nucleophilic addition, condensation reactions, and esterification. This flexibility has enabled researchers to generate a diverse library of analogs with tailored biological activities. For example, by introducing different substituents at strategic positions within the imidazopyridine ring, chemists can modulate potency, selectivity, and pharmacokinetic properties.

The pharmacological profile of 6-Cyanoimidazo[1,2-a]pyridine-2-carboxylic acid has been further explored through computational modeling and high-throughput screening assays. These approaches have revealed potential interactions with proteins such as transcription factors and growth factor receptors. In particular, the compound has been investigated for its ability to interfere with pathways implicated in metabolic disorders. Preliminary data suggest that it may exhibit hypoglycemic effects by modulating insulin signaling or enhancing glucose uptake in target tissues.

From a chemical biology perspective, 6-Cyanoimidazo[1,2-a]pyridine-2-carboxylic acid serves as an excellent tool for understanding enzyme mechanisms and ligand-receptor interactions. Its structural features allow it to act as a probe for studying enzyme kinetics and binding affinities. By employing techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, researchers have gained insights into how this compound interacts with biological targets at the molecular level. These structural insights have been instrumental in guiding the optimization of lead compounds towards higher efficacy and reduced toxicity.

The industrial significance of 6-Cyanoimidazo[1,2-a]pyridine-2-carboxylic acid cannot be overstated. Its synthesis has been refined to achieve high yields and purity through multi-step organic transformations. Advances in catalytic methods have further streamlined its production process, making it more cost-effective for large-scale applications. Pharmaceutical companies are increasingly interested in this compound due to its potential therapeutic applications and commercial viability.

Future directions in the study of 6-Cyanoimidazo[1,2-a]pyridine-2-carboxylic acid include exploring its role in combination therapies and developing novel delivery systems to enhance bioavailability. The compound's versatility makes it an attractive candidate for formulating prodrugs or nanoparticles that can target specific tissues or diseases more effectively. Additionally, computational techniques such as machine learning are being leveraged to predict new derivatives with enhanced pharmacological properties.

In conclusion,6-Cyanoimidazo[1,2-a]pyridine-2-carboxylic acid (CAS No. 1020035-67-9) represents a promising entity in pharmaceutical research with diverse applications across multiple therapeutic areas. Its unique structural features and synthetic adaptability have positioned it as a key intermediate in drug discovery efforts aimed at addressing unmet medical needs.

• 1220039-32-6(7-Methyl-imidazo1,2-apyridine-2-carboxylic acid hydrochloride)
• 80353-93-1(6-Methylimidazo[1,2-a]pyridine-2-carboxylic acid)
• 21801-80-9(7-Methylimidazo1,2-apyridine-3-carboxylic acid)
• 1371567-52-0(8-(hydroxymethyl)-Imidazo[1,2-a]pyridine-3-carboxylic acid)
• 1019021-64-7(6-methylimidazo[1,2-a]pyridine-3-carboxylic acid)
• 80353-94-2(7-Methylimidazo[1,2-a]pyridine-2-carboxylic acid)
• 88751-05-7(8-Methylimidazo[1,2-a]pyridine-2-carboxylic acid)
• 129912-20-5(7-cyano-Imidazo[1,2-a]pyridine-2-carboxylic acid)
• 1019021-71-6(6-Cyanoimidazo[1,2-a]pyridine-3-carboxylic acid)
• 1228376-75-7(8-cyano-6-methyl-Imidazo[1,2-a]pyridine-2-carboxylic acid)